Consistently altered expression of gene sets in postmortem brains of individuals with major psychiatric disorders

Translational Psychiatry

Volumn 6, Issue 9, 2016, Pages

  Darby, M M ^a   Yolken, R H ^a   Sabunciyan, S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TRANSCRIPTOME;

ADULT; AGED; AUTOPSY; BIPOLAR DISORDER; BRAIN; FEMALE; GENE EXPRESSION; GENETICS; HIPPOCAMPUS; HUMAN; MAJOR DEPRESSION; MALE; METABOLISM; MIDDLE AGED; PREFRONTAL CORTEX; SCHIZOPHRENIA; YOUNG ADULT;

ADULT; AGED; AUTOPSY; BIPOLAR DISORDER; BRAIN; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENE EXPRESSION; HIPPOCAMPUS; HUMANS; MALE; MIDDLE AGED; PREFRONTAL CORTEX; RNA, MESSENGER; SCHIZOPHRENIA; TRANSCRIPTOME; YOUNG ADULT;

EID: 85018835648     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/TP.2016.173     Document Type: Article

References (72)

1. Cross-Disorder Group of the Psychiatric Genomics Consortium. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 2013; 381: 1371–1379.
2. Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium, Ripke S, Wray NR, Lewis CM, Hamilton SP, Weissman MM et al. A megaanalysis of genome-wide association studies for major depressive disorder. Mol Psychiatry 2013; 18: 497–511.
3. Network, Pathway Analysis Subgroup of Psychiatric Genomics Consortium. Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways. Nat Neurosci 2015; 18: 199–209.
4. Schizophrenia Working Group of the Psychiatric Genomics C. Biological insights from 108 schizophrenia-associated genetic loci. Nature 2014; 511: 421–427.
5. Schulze TG, Akula N, Breuer R, Steele J, Nalls MA, Singleton AB et al. Molecular genetic overlap in bipolar disorder, schizophrenia, and major depressive disorder. World J Biol Psychiatry 2014; 15: 200–208.
6. Hwang Y, Kim J, Shin JY, Kim JI, Seo JS, Webster MJ et al. Gene expression profiling by mRNA sequencing reveals increased expression of immune/inflammationrelated genes in the hippocampus of individuals with schizophrenia. Transl Psychiatry 2012; 3: e321.
7. Cruceanu C, Tan PP, Rogic S, Lopez JP, Torres-Platas SG, Gigek CO et al. Transcriptome sequencing of the anterior cingulate in bipolar disorder: dysregulation of G protein-coupled receptors. Am J Psychiatry 2015; 172: 1131–1140.
8. Kim S, Hwang Y, Webster MJ, Lee D. Differential activation of immune/inflammatory response-related co-expression modules in the hippocampus across the major psychiatric disorders. Mol Psychiatry 2016; 21: 376–385.
9. Akula N, Wendland JR, Choi KH, McMahon FJ. An integrative genomic study implicates the post-synaptic density in the pathogenesis of bipolar disorder. Neuropsychopharmacology 2015; 41: 886–895.
10. Chen H, Wang N, Zhao X, Ross CA, O'Shea KS, McInnis MG. Gene expression alterations in bipolar disorder postmortem brains. Bipolar Disord 2013; 15: 177–187.
11. de Baumont A, Maschietto M, Lima L, Carraro DM, Olivieri EH, Fiorini A et al. Innate immune response is differentially dysregulated between bipolar disease and schizophrenia. Schizophr Res 2015; 161: 215–221.
12. Shao L, Vawter MP. Shared gene expression alterations in schizophrenia and bipolar disorder. Biol Psychiatry 2008; 64: 89–97.
13. Wu JQ, Wang X, Beveridge NJ, Tooney PA, Scott RJ, Carr VJ et al. Transcriptome sequencing revealed significant alteration of cortical promoter usage and splicing in schizophrenia. PLoS One 2012; 7: e36351.
14. van Erp TG, Hibar DP, Rasmussen JM, Glahn DC, Pearlson GD, Andreassen OA et al. Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. Mol Psychiatry 2016; 21: 585.
15. Wagstyl K, Ronan L, Whitaker KJ, Goodyer IM, Roberts N, Crow TJ et al. Multiple markers of cortical morphology reveal evidence of supragranular thinning in schizophrenia. Transl Psychiatry 2016; 6: e780.
16. Honea R, Crow TJ, Passingham D, Mackay CE. Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies. Am J Psychiatry 2005; 162: 2233–2245.
17. Anderson D, Ardekani BA, Burdick KE, Robinson DG, John M, Malhotra AK et al. Overlapping and distinct gray and white matter abnormalities in schizophrenia and bipolar I disorder. Bipolar Disord 2013; 15: 680–693.
18. Tang J, Liao Y, Zhou B, Tan C, Liu W, Wang D et al. Decrease in temporal gyrus gray matter volume in first-episode, early onset schizophrenia: an MRI study. PLoS One 2012; 7: e40247.
19. Joshi D, Fung SJ, Rothwell A, Weickert CS. Higher gamma-aminobutyric acid neuron density in the white matter of orbital frontal cortex in schizophrenia. Biol Psychiatry 2012; 72: 725–733.
20. Chen YL, Tu PC, Lee YC, Chen YS, Li CT, Su TP. Resting-state fMRI mapping of cerebellar functional dysconnections involving multiple large-scale networks in patients with schizophrenia. Schizophr Res 2013; 149: 26–34.
21. Martinez A, Hillyard SA, Dias EC, Hagler DJ Jr., Butler PD, Guilfoyle DN et al. Magnocellular pathway impairment in schizophrenia: evidence from functional magnetic resonance imaging. J Neurosci 2008; 28: 7492–7500.
22. Seymour K, Stein T, Sanders LL, Guggenmos M, Theophil I, Sterzer P. Altered contextual modulation of primary visual cortex responses in schizophrenia. Neuropsychopharmacology 2013; 38: 2607–2612.
23. Nenadic I, Smesny S, Schlosser RG, Sauer H, Gaser C. Auditory hallucinations and brain structure in schizophrenia: voxel-based morphometric study. Br J Psychiatry 2010; 196: 412–413.
24. Baldacara L, Nery-Fernandes F, Rocha M, Quarantini LC, Rocha GG, Guimaraes JL et al. Is cerebellar volume related to bipolar disorder? J Affect Disord 2011; 135: 305–309.
25. Chepenik LG, Wang F, Spencer L, Spann M, Kalmar JH, Womer F et al. Structurefunction associations in hippocampus in bipolar disorder. Biol Psychol 2012; 90: 18–22.
26. Lacerda AL, Keshavan MS, Hardan AY, Yorbik O, Brambilla P, Sassi RB et al. Anatomic evaluation of the OFC in major depressive disorder. Biol Psychiatry 2004; 55: 353–358.
27. Akula N, Barb J, Jiang X, Wendland JR, Choi KH, Sen SK et al. RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms and GTPase binding in bipolar disorder. Mol Psychiatry 2014; 19: 1179–1185.
28. Weickert CS, Ligons DL, Romanczyk T, Ungaro G, Hyde TM, Herman MM et al. Reductions in neurotrophin receptor mRNAs in the prefrontal cortex of patients with schizophrenia. Mol Psychiatry 2005; 10: 637–650.
29. Hwang Y, Kim J, Shin JY, Kim JI, Seo JS, Webster MJ et al. Gene expression profiling by mRNA sequencing reveals increased expression of immune/inflammationrelated genes in the hippocampus of individuals with schizophrenia. Transl Psychiatry 2013; 3: e321.
30. Zhao Z, Xu J, Chen J, Kim S, Reimers M, Bacanu SA et al. Transcriptome sequencing and genome-wide association analyses reveal lysosomal function and actin cytoskeleton remodeling in schizophrenia and bipolar disorder. Mol Psychiatry 2015; 20: 563–572.
31. Bowden NA, Scott RJ, Tooney PA. Altered gene expression in the superior temporal gyrus in schizophrenia. BMC Genomics 2008; 9: 199.
32. Fatemi SH, Folsom TD, Rooney RJ, Thuras PD. Expression of GABAA alpha2-, beta1-and epsilon-receptors are altered significantly in the lateral cerebellum of subjects with schizophrenia, major depression and bipolar disorder. Transl Psychiatry 2013; 3: e303.
33. Hashimoto R, Straub RE, Weickert CS, Hyde TM, Kleinman JE, Weinberger DR. Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia. Mol Psychiatry 2004; 9: 299–307.
34. Ryan MM, Lockstone HE, Huffaker SJ, Wayland MT, Webster MJ, Bahn S. Gene expression analysis of bipolar disorder reveals downregulation of the ubiquitin cycle and alterations in synaptic genes. Mol Psychiatry 2006; 11: 965–978.
35. Sinclair D, Webster MJ, Fullerton JM, Weickert CS. Glucocorticoid receptor mRNA and protein isoform alterations in the OFC in schizophrenia and bipolar disorder. BMC Psychiatry 2012; 12: 84.
36. Aberg KA, McClay JL, Nerella S, Clark S, Kumar G, Chen W et al. Methylome-wide association study of schizophrenia: identifying blood biomarker signatures of environmental insults. JAMA Psychiatry 2014; 71: 255–264.
37. Montano C, Taub MA, Jaffe A, Briem E, Feinberg JI, Trygvadottir R et al. Association of DNA methylation differences with schizophrenia in an epigenome-wide association study. JAMA Psychiatry 2016; 73: 506–514.
38. van den Oord EJ, Clark SL, Xie LY, Shabalin AA, Dozmorov MG, Kumar G et al. A whole methylome CpG-SNP association study of psychosis in blood and brain tissue. Schizophr Bull 2016; 42: 1018–1026.
39. Cai C, Langfelder P, Fuller TF, Oldham MC, Luo R, van den Berg LH et al. Is human blood a good surrogate for brain tissue in transcriptional studies? BMC Genomics 2010; 11: 589.
40. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005; 102: 15545–15550.
41. Torrey EF, Webster M, Knable M, Johnston N, Yolken RH. The Stanley foundation brain collection and neuropathology consortium. Schizophr Res 2000; 44: 151–155.
42. Kim D, Pertea G, Trapnell C, Pimentel H, Kelley R, Salzberg SL. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol 2013; 14: R36.
43. Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 2014; 15: 550.
44. Merico D, Isserlin R, Stueker O, Emili A, Bader GD. Enrichment map: a networkbased method for gene-set enrichment visualization and interpretation. PLoS One 2010; 5: e13984.
45. Saito R, Smoot ME, Ono K, Ruscheinski J, Wang PL, Lotia S et al. A travel guide to Cytoscape plugins. Nat Methods 2012; 9: 1069–1076.
46. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 2003; 13: 2498–2504.
47. Mudge J, Miller NA, Khrebtukova I, Lindquist IE, May GD, Huntley JJ et al. Genomic convergence analysis of schizophrenia: mRNA sequencing reveals altered synaptic vesicular transport in post-mortem cerebellum. PLoS One 2008; 3: e3625.
48. Sawai H, Takai-Igarashi T, Tanaka H. Identification of collaborative activities with oxidative phosphorylation in bipolar disorder. Bioinformation 2015; 11: 207–216.
49. Focking M, Lopez LM, English JA, Dicker P, Wolff A, Brindley E et al. Proteomic and genomic evidence implicates the postsynaptic density in schizophrenia. Mol Psychiatry 2015; 20: 424–432.
50. Schubert KO, Focking M, Cotter DR. Proteomic pathway analysis of the hippocampus in schizophrenia and bipolar affective disorder implicates 14-3-3 signaling, aryl hydrocarbon receptor signaling, and glucose metabolism: potential roles in GABAergic interneuron pathology. Schizophr Res 2015; 167: 64–72.
51. Wikenheiser AM, Schoenbaum G. Over the river, through the woods: cognitive maps in the hippocampus and OFC. Nat Rev Neurosci 2016; 17: 513–523.
52. International Schizophrenia C, Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009; 460: 748–752.
53. Topol A, English JA, Flaherty E, Rajarajan P, Hartley BJ, Gupta S et al. Increased abundance of translation machinery in stem cell-derived neural progenitor cells from four schizophrenia patients. Transl Psychiatry 2015; 5: e662.
54. Zubenko GS, Hughes HB 3rd, Jordan RM, Lyons-Weiler J, Cohen BM. Differential hippocampal gene expression and pathway analysis in an etiology-based mouse model of major depressive disorder. Am J Med Genet B Neuropsychiatr Genet 2014; 165B: 457–466.
55. Graber TE, Hebert-Seropian S, Khoutorsky A, David A, Yewdell JW, Lacaille JC et al. Reactivation of stalled polyribosomes in synaptic plasticity. Proc Natl Acad Sci USA 2013; 110: 16205–16210.
56. Heise C, Gardoni F, Culotta L, di Luca M, Verpelli C, Sala C. Elongation factor-2 phosphorylation in dendrites and the regulation of dendritic mRNA translation in neurons. Front Cell Neurosci 2014; 8: 35.
57. Duman RS, Li N, Liu RJ, Duric V, Aghajanian G. Signaling pathways underlying the rapid antidepressant actions of ketamine. Neuropharmacology 2012; 62: 35–41.
58. Horvath S, Mirnics K. Schizophrenia as a disorder of molecular pathways. Biol Psychiatry 2015; 77: 22–28.
59. Horvath S, Mirnics K. Immune system disturbances in schizophrenia. Biol Psychiatry 2014; 75: 316–323.
60. Khandaker GM, Cousins L, Deakin J, Lennox BR, Yolken R, Jones PB. Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment. Lancet Psychiatry 2015; 2: 258–270.
61. Garbett KA, Vereczkei A, Kalman S, Brown JA, Taylor WD, Faludi G et al. Coordinated messenger RNA/microRNA changes in fibroblasts of patients with major depression. Biol Psychiatry 2015; 77: 256–265.
62. Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009; 460: 748–752.
63. Morgan LZ, Rollins B, Sequeira A, Byerley W, DeLisi LE, Schatzberg AF et al. Quantitative trait locus and brain expression of HLA-DPA1 offers evidence of shared immune alterations in psychiatric disorders. Microarrays (Basel) 2016; 5: (doi:10.3390/microarrays5010006).
64. Choi KH, Elashoff M, Higgs BW, Song J, Kim S, Sabunciyan S et al. Putative psychosis genes in the prefrontal cortex: combined analysis of gene expression microarrays. BMC Psychiatry 2008; 8: 87.
65. Sequeira A, Morgan L, Walsh DM, Cartagena PM, Choudary P, Li J et al. Gene expression changes in the prefrontal cortex, anterior cingulate cortex and nucleus accumbens of mood disorders subjects that committed suicide. PLoS One 2012; 7: e35367.
66. Montalbetti N, Simonin A, Kovacs G, Hediger MA. Mammalian iron transporters: families SLC11 and SLC40. Mol Aspects Med 2013; 34: 270–287.
67. Xu J, Sun J, Chen J, Wang L, Li A, Helm M et al. RNA-Seq analysis implicates dysregulation of the immune system in schizophrenia. BMC Genomics 2011; 13 Suppl 8: S2.
68. Chen YH, Tsai MT, Shaw CK, Chen CH. Mutation analysis of the human NR4A2 gene, an essential gene for midbrain dopaminergic neurogenesis, in schizophrenic patients. Am J Med Genet 2001; 105: 753–757.
69. Xing G, Zhang L, Russell S, Post R. Reduction of dopamine-related transcription factors Nurr1 and NGFI-B in the prefrontal cortex in schizophrenia and bipolar disorders. Schizophr Res 2006; 84: 36–56.
70. Guillozet-Bongaarts AL, Hyde TM, Dalley RA, Hawrylycz MJ, Henry A, Hof PR et al. Altered gene expression in the dorsolateral prefrontal cortex of individuals with schizophrenia. Mol Psychiatry 2014; 19: 478–485.
71. Tatro ET, Everall IP, Masliah E, Hult BJ, Lucero G, Chana G et al. Differential expression of immunophilins FKBP51 and FKBP52 in the frontal cortex of HIVinfected patients with major depressive disorder. J Neuroimmune Pharmacol 2009; 4: 218–226.
72. Sinclair D, Fillman SG, Webster MJ, Weickert CS. Dysregulation of glucocorticoid receptor co-factors FKBP5, BAG1 and PTGES3 in prefrontal cortex in psychotic illness. Sci Rep 2013; 3: 3539.